Children with pulmonary hypertension (PH) engage in fewer and shorter bouts of intense physical activity than their peers, according…
Articles by Marisa Wexler, MS
The first participant has been enrolled in a two-part Phase 3 clinical trial testing IKT-001, Inhibikase Therapeutics’ experimental formulation…
Patients with interstitial lung diseases (ILDs) who require supplemental oxygen are more than three times as likely to experience…
Anumana‘s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the…
In a large clinical trial, treatment with Winrevair (sotatercept-csrk) significantly reduced pressure in the lungs’ blood…
A history of smoking was associated with worse survival outcomes in male patients with pulmonary arterial hypertension (PAH), according…
Winrevair (sotatercept-csrk), an injection therapy approved for adults with pulmonary arterial hypertension (PAH), is now covered by several…
Measuring levels of tiny pieces of genetic material in the blood, known as microRNAs, may help identify group 2…
A study found that a naturally occurring signaling molecule called C-type natriuretic peptide (CNP) reduced the severity of pulmonary…
Cereno Scientific has been cleared to launch a Phase 1 clinical trial in Sweden to evaluate the pharmacological properties…
People with pulmonary arterial hypertension (PAH) often have abnormalities in the coronary microvasculature, or the tiny blood vessels…
Following positive results from a Phase 3 clinical study, United Therapeutics plans to submit an application to the U.S.